Ascletis Pharma Inc. (ASCLF)
USD 0.24
(0.0%)
USD 0.24
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.49 Billion CNY | -6.25% |
| 2022 | 2.65 Billion CNY | -6.11% |
| 2021 | 2.82 Billion CNY | -7.73% |
| 2020 | 3.06 Billion CNY | -10.49% |
| 2019 | 3.42 Billion CNY | -2.87% |
| 2018 | 3.52 Billion CNY | 255.87% |
| 2017 | 991.25 Million CNY | 84.84% |
| 2016 | 536.26 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.27 Billion CNY | -8.63% |
| 2024 Q2 | 2.27 Billion CNY | 0.0% |
| 2023 Q2 | 2.65 Billion CNY | 0.0% |
| 2023 Q1 | 2.65 Billion CNY | 0.1% |
| 2023 FY | 2.49 Billion CNY | -6.25% |
| 2023 Q4 | 2.49 Billion CNY | 0.0% |
| 2023 Q3 | 2.49 Billion CNY | -6.35% |
| 2022 Q2 | 2.82 Billion CNY | 0.0% |
| 2022 FY | 2.65 Billion CNY | -6.11% |
| 2022 Q1 | 2.82 Billion CNY | -0.28% |
| 2022 Q4 | 2.65 Billion CNY | 0.0% |
| 2022 Q3 | 2.65 Billion CNY | -5.85% |
| 2021 FY | 2.82 Billion CNY | -7.73% |
| 2021 Q3 | 2.82 Billion CNY | -3.71% |
| 2021 Q4 | 2.82 Billion CNY | 0.0% |
| 2021 Q1 | 2.93 Billion CNY | -4.18% |
| 2021 Q2 | 2.93 Billion CNY | 0.0% |
| 2020 Q2 | 3.38 Billion CNY | 0.0% |
| 2020 Q3 | 3.06 Billion CNY | -9.49% |
| 2020 Q4 | 3.06 Billion CNY | 0.0% |
| 2020 FY | 3.06 Billion CNY | -10.49% |
| 2020 Q1 | 3.38 Billion CNY | -1.11% |
| 2019 Q2 | 3.47 Billion CNY | 0.0% |
| 2019 FY | 3.42 Billion CNY | -2.87% |
| 2019 Q4 | 3.42 Billion CNY | 0.0% |
| 2019 Q3 | 3.42 Billion CNY | -1.29% |
| 2019 Q1 | 3.47 Billion CNY | -1.6% |
| 2018 Q1 | 889.9 Million CNY | -10.22% |
| 2018 FY | 3.52 Billion CNY | 255.87% |
| 2018 Q4 | 3.52 Billion CNY | 0.0% |
| 2018 Q3 | 3.52 Billion CNY | 274.8% |
| 2018 Q2 | 941.18 Million CNY | 5.76% |
| 2017 FY | 991.25 Million CNY | 84.84% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q3 | 991.25 Million CNY | 0.0% |
| 2017 Q4 | 991.25 Million CNY | 0.0% |
| 2016 FY | 536.26 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -651694.587% |
| CSL Limited | 38.02 Billion USD | 93.449% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -6312.359% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -34402.647% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -3262347.285% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -23502.511% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -1813.059% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -3442184.253% |
| Mesoblast Limited | 667.9 Million USD | -272.961% |
| Marizyme, Inc. | 22.01 Million USD | -11215.015% |
| Genus plc | 1.02 Billion USD | -142.104% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -183284.511% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -499061.188% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -397190.112% |
| ContraFect Corporation | 20.67 Million USD | -11946.081% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -638021.404% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | 31.33 Million USD | -7849.914% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -59981.905% |
| MultiCell Technologies, Inc. | 126.22 USD | -1973545296.926% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -264988.662% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -1838.378% |
| EV Biologics, Inc. | 431.71 Thousand USD | -576904.452% |
| Q BioMed Inc. | 3.51 Million USD | -70757.544% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -6980.955% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -953297.735% |
| Biomind Labs Inc. | 73.81 Thousand USD | -3374382.179% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -8199.227% |
| Skye Bioscience, Inc. | 11.94 Million USD | -20762.004% |
| SQZ Biotechnologies Company | 107.18 Million USD | -2223.984% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -90603.028% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -127109.835% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -173849.255% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -362235.96% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -323137.318% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | -438.185% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -75088.65% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -95590.413% |
| GB Sciences, Inc. | 103.44 Thousand USD | -2408021.459% |
| Alpha Cognition Inc. | 2.45 Million USD | -101483.862% |
| argenx SE | 4.54 Billion USD | 45.162% |
| HST Global, Inc. | 1526.00 USD | -163237711.271% |
| Halberd Corporation | 10.13 Thousand USD | -24587887.366% |
| Enzolytics Inc. | 361.7 Million USD | -588.682% |
| Resverlogix Corp. | 8.11 Million USD | -30596.352% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -132550.063% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -8814.289% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -458.136% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -5122.022% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -171830.913% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -389329.475% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -10934490.229% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -27735.131% |
| AVAX Technologies, Inc. | 7.37 Million USD | -33666.517% |
| ONE Bio Corp. | 70.08 Million USD | -3454.243% |
| Zenith Capital Corp. | 7410.00 USD | -33616755.601% |
| Genscript Biotech Corporation | 3.38 Billion USD | 26.44% |
| Ember Therapeutics, Inc. | 184.00 USD | -1353809139.13% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -773971.646% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -952980.378% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -268338.975% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -252034.839% |
| Agentix Corp. | 261.39 Thousand USD | -952878.285% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 2.3 Million USD | -108012.956% |
| Helix BioMedix, Inc. | 3.02 Million USD | -82245.064% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -4626.683% |
| BioStem Technologies, Inc. | 14.56 Million USD | -17008.236% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -4362896.112% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -107835787.446% |
| LadRx Corporation | 2.3 Million USD | -107834.851% |
| Cell Source, Inc. | 195.17 Thousand USD | -1276221.277% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -518258.696% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -704337.004% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -704337.004% |
| NovAccess Global Inc. | 62.24 Thousand USD | -4001649.454% |
| Affymax, Inc. | 7.44 Million USD | -33367.809% |
| Itoco Inc. | 1.4 Million USD | -177820.064% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -2604005.293% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -2349908.491% |
| CytoDyn Inc. | 11.13 Million USD | -22268.974% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -1742205.486% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -13931717.673% |
| Qrons Inc. | 420.00 USD | -593097280.952% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -646124.748% |
| SYBLEU INC | 330.46 Thousand USD | -753682.212% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -451071.666% |
| Rebus Holdings, Inc. | 5000.00 USD | -49820080.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -608320.896% |
| Mobile Lads Corp. | 52.00 USD | -4790401823.077% |
| International Stem Cell Corporation | 5.39 Million USD | -46115.38% |
| Bioxytran, Inc. | 137.63 Thousand USD | -1809726.501% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -16504.701% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -14925.086% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -3153075.949% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -287985.493% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -33038.34% |
| Neutra Corp. | 2851.00 USD | -87373067.31% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -7586.876% |
| PureTech Health plc | 693.97 Million USD | -258.949% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -30763.357% |
| IXICO plc | 15.84 Million USD | -15622.193% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -29977.385% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -2310.872% |
| CSL Limited | 38.02 Billion USD | 93.449% |
| Cellectis S.A. | 333.99 Million USD | -645.823% |